Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced the release of a new version of Genedata Profiler™, its open, interoperable enterprise software platform designed to facilitate efficient omics-based patient and compound profiling processes. Release 9.1 of the software platform for precision medicine provides significant advances over the initial version launched in April this year and will be offered as an update to existing users of Genedata Profiler at no additional cost.
Genedata Profiler is easily integrated with existing in-house and public data sources, using its public APIs. In early 2014, Genedata implemented a bi-directional integration with tranSMART for Pfizer, and recently announced the completion of a significant milestone in a project for another major pharmaceutical company to integrate Genedata Profiler with the open source middleware software system iRODS. The latter integration created an advanced security-hardened research data platform for the management, processing and analysis of exploratory NGS and other omics data from patients and pre-clinical experiments. Genedata Profiler 9.1 adds support for iRODS, marrying security with performance. Members of the research team can now benefit from intuitive raw data management, including visualization of clinical sample annotation together with raw data, metadata search across the whole database, and powerful annotation curation capabilities including bulk editing and annotation information protection.
In producing Release 9.1 of Genedata Profiler, developers at Genedata considered the requirements of all users of the software in typical biopharma research teams, in particular bioinformaticians, translational researchers, analysts and biologists. Highlights of Release 9.1 include:
Dr. Othmar Pfannes, CEO of Genedata, commented: “With Release 9.1 of Genedata Profiler, we see a significant step forward, cementing our commitment to becoming the leading provider of translational research software. The added functionality will be highly appreciated by all members of the typical translational R&D team, further reducing the time required to process complex workflows and lightening the load of team members. Genedata continues to evolve and improve its product range, and we are already planning further updates for Genedata Profiler, for example in the area of enhanced sample annotation management.”
Genedata transforms data into intelligence with a portfolio of advanced software solutions, which make research data accessible and understandable and research processes more efficient. These solutions are used worldwide by leading pharmaceutical, industrial, and agricultural biotechnology companies as well as academic research organizations. Genedata innovations enable scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Germany, Japan, and the US.
Phone: +41 61 511 85 61
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
All product and service names mentioned are the trademarks of their respective companies.